New technology to analyze cells in 3D for better understanding of diseases
Gel-based Optical-isolation Single-Cell 3D Spatial Multiomics
This study is exploring a new way to look at cells in 3D using a special gel, which could help us better understand how cells work and relate to diseases, especially in the brain, so that patients can benefit from improved treatments.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California-Irvine NIH-funded |
| Lab location | 1 site (Irvine, United States) |
| Project ID | NIH-10473394 on NIH RePORTER |
What this research studies
This research focuses on developing a novel technology called gel-based optical isolation for analyzing cells in three-dimensional space. By examining proteins, RNAs, and DNAs within whole tissues, this approach aims to preserve spatial information that is often lost in traditional single-cell analysis. Patients may benefit from this research as it could lead to improved understanding of how cells function and contribute to diseases, particularly in the brain. The methodology involves advanced imaging techniques and high-throughput profiling to capture detailed cellular information.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals with neurological disorders or diseases that affect cellular function in the brain.
Not a fit: Patients with conditions unrelated to cellular function or those who do not have access to the research facility may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to breakthroughs in understanding and treating diseases by providing detailed insights into cellular functions and interactions.
How similar studies have performed: While the approach is innovative, similar technologies in spatial omics have shown promise, indicating potential for success in this novel application.
Where this research is happening
Irvine, United States
- University of California-Irvine — Irvine, United States (Active)
Researchers
- Principal investigator: Shi, Xiaoyu — University of California-Irvine
- Study coordinator: Shi, Xiaoyu
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.